Kontour Medical(SH:688314) Cai Jing Wang·2025-09-17 08:44Group 1 - The core viewpoint of the news is that 康拓医疗 is actively expanding its global presence through its subsidiary BIOPLATE, which is focused on enhancing profitability and market access in various countries [1] - BIOPLATE has significantly reduced its losses in the first half of 2025 compared to the same period last year by improving operational efficiency and diversifying its product line [1] - The company has achieved product market access in nearly 40 countries or regions and plans to expand its team and resources to grow its business scale [1] Group 2 - The PEEK bone plate production line in the United States has officially commenced operations, and the company is actively promoting its products in the market [1] - The management addressed concerns regarding the slight decline in gross margin by implementing aggressive marketing strategies and optimizing production processes to stabilize margins [1] - In the new business areas of oral, thoracic surgery, and maxillofacial repair, the company is expanding its "优贝雅" brand implant system and has acquired equity in 蝾螈生物 to enhance its product offerings in the oral implant market [2]